(Q30402355)

2 September 2017

Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice (English)

1 reference

2 September 2017

6

Wim Jiskoot

1 reference

2 September 2017

Miranda M C van Beers

1

1 reference

2 September 2017

Melody Sauerborn

2

1 reference

2 September 2017

Francesca Gilli

3

1 reference

2 September 2017

Vera Brinks

4

1 reference

2 September 2017

Huub Schellekens

5

1 reference

2 September 2017

language of work or name

1 reference

5 May 2011

1 reference

2 September 2017

Pharmaceutical Research

1 reference

2 September 2017

28

1 reference

2 September 2017

10

1 reference

2 September 2017

2393-2402

1 reference

Neutralizing antibodies against interferon-Beta

2 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Light-induced aggregation of type I soluble tumor necrosis factor receptor.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Immunogenicity of therapeutic proteins. Part 1: impact of product handling

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Effects of protein aggregates: an immunologic perspective

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Structure-immunogenicity relationships of therapeutic proteins

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Immunogenicity of therapeutic proteins: clinical implications and future prospects

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Protein formulation and fill-finish operations.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Bioequivalence and the immunogenicity of biopharmaceuticals

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Quantification and significance of protein oxidation in biological samples

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

The crystal structure of human interferon beta at 2.2-A resolution

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

The long-term stability of recombinant (serine-17) human interferon-beta.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Calculation of protein extinction coefficients from amino acid sequence data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3170469

Development of a transgenic mouse model immune tolerant for human interferon Beta.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-011-0451-4

Mechanisms of protein damage induced by cysteine thiyl radical formation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-011-0451-4

Determinants of autoantibody induction by conjugated papillomavirus virus-like particles

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11095-011-0451-4

The structure of human interferon-beta: implications for activity

21 January 2018

1 reference

12 December 2020

The influence of antigen organization on B cell responsiveness

1 reference

12 December 2020

Development of HSA-free formulations for a hydrophobic cytokine with improved stability

1 reference

12 December 2020

Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta

1 reference

12 December 2020

Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation

1 reference

12 December 2020

Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2

1 reference

12 December 2020

Quantitation of aromatic residues in proteins: model compounds for second-derivative spectroscopy

1 reference

12 December 2020

Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity

1 reference

12 December 2020

10.1007/S11095-011-0451-4

Identifiers

DOI

1 reference

2 September 2017

1 reference

2 September 2017

PubMed publication ID

21544687

1 reference